MANE
Veradermics, Incorporated · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +30.0% ·
net new positions +20.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 1.83M | New | $115.29M | 0.1% | New | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 1.79M | New | $113.22M | 0.0% | New | 1 | SEC ↗ ×4 |
| 3 | Viking Global Investors ✦ | 1.69M | New | $106.76M | 0.3% | New | 1 | SEC ↗ |
| 4 | Adage Capital Partners ✦ | 1.10M | New | $69.47M | 0.1% | New | 1 | SEC ↗ |
| 5 | Aberdeen Group plc | 1.05M | New | $66.60M | 0.1% | New | 1 | SEC ↗ |
| 6 | JPMorgan Chase ✦ | 976.17K | New | $59.40M | 0.0% | New | 1 | SEC ↗ ×4 |
| 7 | Vanguard Capital Management Llc | 699.64K | — | $44.18M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 654.60K | New | $41.34M | 0.0% | New | 1 | SEC ↗ ×3 |
| 9 | Balyasny Asset Management L.P. | 532.91K | New | $33.65M | 0.1% | New | 1 | SEC ↗ |
| 10 | Ameriprise Financial Inc | 514.03K | New | $32.46M | 0.0% | New | 1 | SEC ↗ ×2 |
| 11 | Wellington Management ✦ | 477.83K | New | $30.18M | 0.0% | New | 1 | SEC ↗ ×5 |
| 12 | UBS Group AG | 347.07K | New | $21.92M | 0.0% | New | 1 | SEC ↗ ×2 |
| 13 | Stifel Financial Corp | 294.12K | New | $18.57M | 0.0% | New | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passive) | 282.61K | New | $17.85M | 0.0% | New | 1 | SEC ↗ ×3 |
| 15 | Franklin Resources Inc | 200.00K | New | $12.63M | 0.0% | New | 1 | SEC ↗ |
| 16 | Geode Capital Management ✦ (passive) | 178.21K | New | $11.26M | 0.0% | New | 1 | SEC ↗ ×2 |
| 17 | Goldman Sachs Group ✦ | 168.97K | New | $10.67M | 0.0% | New | 1 | SEC ↗ |
| 18 | Ensign Peak Advisors, Inc | 150.00K | New | $9.47M | 0.0% | New | 1 | SEC ↗ |
| 19 | Jennison Associates Llc | 141.78K | New | $8.95M | 0.0% | New | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 134.22K | New | $8.48M | 0.0% | New | 1 | SEC ↗ |
| 21 | Millennium Management ✦ | 123.22K | New | $7.78M | 0.0% | New | 1 | SEC ↗ |
| 22 | Charles Schwab Investment… | 98.01K | New | $6.19M | 0.0% | New | 1 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (passive) | 74.40K | New | $4.70M | 0.0% | New | 1 | SEC ↗ |
| 24 | Bank Of America Corp /De/ | 65.67K | New | $4.15M | 0.0% | New | 1 | SEC ↗ |
| 25 | Bamco Inc /Ny/ | 59.67K | New | $3.77M | 0.0% | New | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 51.69K | New | $3.26M | 0.0% | New | 1 | SEC ↗ ×4 |
| 27 | Barclays Plc | 36.91K | New | $2.33M | 0.0% | New | 1 | SEC ↗ ×3 |
| 28 | Northern Trust Corp | 34.54K | New | $2.18M | 0.0% | New | 1 | SEC ↗ |
| 29 | First Trust Advisors Lp | 19.77K | New | $1.25M | 0.0% | New | 1 | SEC ↗ |
| 30 | Squarepoint Ops LLC | 16.61K | New | $1.05M | 0.0% | New | 1 | SEC ↗ |
| 31 | Toronto Dominion Bank | 13.43K | New | $847,978 | 0.0% | New | 1 | SEC ↗ |
| 32 | CIBC Bancorp USA Inc. | 13.10K | — | $827,265 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Citigroup Inc | 10.69K | New | $675,137 | 0.0% | New | 1 | SEC ↗ |
| 34 | Legal & General Group Plc | 7.11K | New | $448,681 | 0.0% | New | 1 | SEC ↗ |
| 35 | Bank of New York Mellon Corp | 3.67K | New | $231,634 | 0.0% | New | 1 | SEC ↗ |
| 36 | Us Bancorp \De\ | 470 | New | $29,681 | 0.0% | New | 1 | SEC ↗ |
| 37 | Royal Bank Of Canada | 8 | New | $1,000 | 0.0% | New | 1 | SEC ↗ |
| 38 | Jones Financial Companies Lllp | 10 | New | $655 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Citadel Advisors | $115.29M | 0.1% |
| Fidelity (FMR) | $113.22M | 0.0% |
| Viking Global Investors | $106.76M | 0.3% |
| Adage Capital Partners | $69.47M | 0.1% |
| Aberdeen Group plc | $66.60M | 0.1% |
| JPMorgan Chase | $59.40M | 0.0% |
| Marshall Wace | $41.34M | 0.0% |
| Balyasny Asset Management L.P. | $33.65M | 0.1% |
| Ameriprise Financial Inc | $32.46M | 0.0% |
| Wellington Management | $30.18M | 0.0% |
| UBS Group AG | $21.92M | 0.0% |
| Stifel Financial Corp | $18.57M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 79 holders, 24.94M shares, $1.57B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 690.60K sh · $74.07M
Director · 59.40K sh · $6.37M
Officer · 16.31K sh · $1.75M
Officer · 16.77K sh · $1.82M
Officer · 2.35K sh · $256,730
Officer · 161 sh · $17,916
Officer · 7.92K sh · $844,930
Director · 80.00K sh · $8.58M
Director · 5.00K sh · $541,200
Director · 15.00K sh · $1.59M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
8.8% of class · View original SEC filing ↗
4.9% of class · View original SEC filing ↗